Fabiani J E, Paulin P, Simkin G, Leoni J, Palombarani S, Squiquera L
Rev Alerg Mex (1987). 1989 May-Jun;36(3):99-104.
Hereditary angioedema (HAE) is an inherited deficiency of the inhibitor of C1 esterase (C1 inh). Two types of genetic C1 inh deficiency have been described, type I: quantitative, and type II: functional. For the purpose of the present study, 4 out of 51 HAE patients were selected. None of them had received any previous androgenic therapy. The group was integrated by two type I and one type II cases. All patients that entered in the protocol received 400 mg/day of danazol over 14 days. The complement system was evaluated by monitoring C4, Hemolytic complement 50% (CH50), Circulating Immune Complexes (CIC), and antigenic and functional C1 INH during the study. The level of the complement factors at the beginning and the end of this period demonstrated a statistically significant increase of C4 and CH50 and the disappearance of CIC, while C1INH remained unmodified. These results suggest that the therapeutic effect of Danazol may have two mechanisms of action: i. promotion of C4 synthesis by anabolic effect resulting in an improvement of the complement system with the disappearance of CIC, and ii, a minor increase of C1 inh level primarily due to the lack of its consumption.
遗传性血管性水肿(HAE)是一种遗传性的C1酯酶抑制剂(C1 inh)缺乏症。已描述了两种遗传性C1 inh缺乏症类型,I型:定量缺乏,II型:功能缺乏。在本研究中,从51例HAE患者中选取了4例。他们之前均未接受过任何雄激素治疗。该组包括2例I型和1例II型病例。所有纳入该方案的患者在14天内每天接受400 mg达那唑治疗。在研究期间,通过监测C4、50%溶血补体(CH50)、循环免疫复合物(CIC)以及抗原性和功能性C1 INH来评估补体系统。在此期间开始和结束时的补体因子水平显示,C4和CH50有统计学意义的升高,CIC消失,而C1INH保持不变。这些结果表明,达那唑的治疗作用可能有两种机制:i. 通过合成代谢作用促进C4合成,从而改善补体系统并使CIC消失;ii. C1 inh水平略有升高,主要是由于其消耗减少。